Jean-michel M. Petit

Dijon, 21000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 104 publications

Bedside amputation surgery for isolated toe necrosis in diabetes units as an alternative to conventional amputation in surgery units.

Bedside amputation surgery for isolated toe necrosis in diabetes units as an alternative to conventional amputation in surgery units.

Journal: Diabetes & metabolism

Published: November 12, 2025

Management of patients with type 2 diabetes and MASLD: An overview and joint statement.

Management of patients with type 2 diabetes and MASLD: An overview and joint statement.

Journal: Diabetes & metabolism

Published: October 02, 2025

Diabetes Phenotypes in Patients Presenting a Myocardial Infarction: Progress Towards Precision Medicine?

Diabetes Phenotypes in Patients Presenting a Myocardial Infarction: Progress Towards Precision Medicine?

Journal: Journal of personalized medicine

Published: July 28, 2025

Plasma sphingolipids predict advanced liver fibrosis development in patients with type 2 diabetes.

Plasma sphingolipids predict advanced liver fibrosis development in patients with type 2 diabetes.

Journal: Diabetes, obesity & metabolism

Published: July 10, 2025

Evolution of myocardial steatosis in high cardiovascular risk T2DM patients treated by GLP1 receptor agonists: LICAS study.

Evolution of myocardial steatosis in high cardiovascular risk T2DM patients treated by GLP1 receptor agonists: LICAS study.

Journal: Diabetes research and clinical practice

Published: November 26, 2024

Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Advanced Fibrosis in Diabetology: A Prospective Multicenter Study.

Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Advanced Fibrosis in Diabetology: A Prospective Multicenter Study.

Journal: Diabetes care

Published: September 22, 2024

Plasma 16:0 ceramide as a marker of cardiovascular risk estimated by carotid intima-media thickness in people with type 2 diabetes.

Plasma 16:0 ceramide as a marker of cardiovascular risk estimated by carotid intima-media thickness in people with type 2 diabetes.

Journal: Diabetes & metabolism

Published: March 27, 2024

No effect of liraglutide on high density lipoprotein apolipoprotein AI kinetics in patients with type 2 diabetes.

No effect of liraglutide on high density lipoprotein apolipoprotein AI kinetics in patients with type 2 diabetes.

Journal: Diabetes & metabolism

Published: December 28, 2023

Reply: Concerns regarding the use of Fatty Liver Index in studies of lean NAFLD.

Reply: Concerns regarding the use of Fatty Liver Index in studies of lean NAFLD.

Journal: Hepatology (Baltimore, Md.)

Published: November 27, 2023

Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes.

Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes.

Journal: Cardiovascular diabetology

Published: August 28, 2023

Impact of a Tripartite Collaboration between Oncologist, Pharmacist and Diabetologist in the Management of Patients with Diabetes Starting Chemotherapy: The ONCODIAB Trial.

Impact of a Tripartite Collaboration between Oncologist, Pharmacist and Diabetologist in the Management of Patients with Diabetes Starting Chemotherapy: The ONCODIAB Trial.

Journal: Cancers

Published: August 07, 2023

Inflammation and oxidative stress markers in type 2 diabetes patients with Advanced Carotid atherosclerosis.

Inflammation and oxidative stress markers in type 2 diabetes patients with Advanced Carotid atherosclerosis.

Journal: Cardiovascular diabetology

Published: July 17, 2023

Showing 1-12 of 104

Last Updated: 09/26/2026